REGENXBIO INC. (RGNX)

Clinical trial NCT04597385 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-09-01 → 2028-10-01 3. primary completion date: 2025-09-01 → 2028-10-01 4. enrollment: 12 → 27 participants 5. enrollment type: ESTIMATED → ACTUAL

ELI LILLY & CO (LLY)

Clinical trial NCT06916078 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-13 3. primary completion date: 2026-07-01 → 2026-07-13 4. enrollment: 33 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL